COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

Aerial view of Geisel Library Toward West, UC San Diego. Copyright ©️ the Board of Regents of the University of California. <br>This image is for use in official UC San Diego marketing and promotional materials only.Altman Clinical and Translational Research Institute at UC San Diego Health Sciences. Image credit: UC San DiegoNAFLD Research Center Team NASH Day group photoAltman Clinical and Translational Research Institute at UC San Diego Health Sciences. Credit: Paul Turang.

​The UC San Diego NAFLD Research Center is dedicated to performing cutting-edge translational research in all aspects of nonalcoholic fatty liver disease (NAFLD). Responding to the needs of our patients, we pursue more effective treatments and less invasive diagnostic and monitoring methods. Center Director Rohit Loomba, MD, MHSc, leads a multidisciplinary team of trainees, nurses, clinicians and scientists.

Dr. Rohit Loomba

Rohit Loomba, MD, MHSc, is a leading expert in translational research and innovative clinical trial design in nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH).  He is the founding director of the UCSD NAFLD Translational Research Unit where his team is conducting cutting edge research in all aspects of NAFLD including non-invasive biomarkers, genetics, epidemiology, clinical trial design, imaging end-points, and integrated OMICs using microbiome, metabolome and lipidome. More

Recent Publications

First-Degree Relatives of Patients with NAFLD at Risk of Liver Disease

In a new study, researchers at the University of California San Diego School of Medicine found that first-degree relatives of patients with NAFLD characterized by advanced fibrosis are at a 15% risk of developing the condition.

“Until now, first-degree relatives accompanying their loved ones with liver disease for medical treatment didn’t know they were at a greater risk of developing advanced fibrosis themselves,” said Rohit Loomba, MD, the study’s first author, professor in the Division of Gastroenterology at UC San Diego School of Medicine and director of hepatology at UC San Diego Health.

The results, published in the online edition of Journal of Clinical Investigation, shine a spotlight on the importance of early screening of both siblings and offspring of patients with NAFLD. More from the UC San Diego Newsroom

Find Us



Contact Us

      9452 Medical Center Dr.
      La Jolla, CA 92037
      Phone: (858) 246-5417
      Fax: (858) 246-2255


Photo credits for the above: Aerial wide shot of UC San Diego campus and Altman Clinical and Translational Research Institute at UC San Diego credit: UC San Diego Publications. All photos copyright Regents of the University of California.